Mingqian Feng
- Molecular Biology
- Immunology top 10%
- Oncology top 10%
- Radiology, Nuclear Medicine and Imaging top 5%
- Hepatology top 5%
- Co-authors
- Mitchell HoWei GaoDimiter S. DimitrovYen PhungHeungnam KimXin Wei WangMin QianYan‐Gao Man
- Topics
- Monoclonal and Polyclonal Antibodies Research (14 papers)Glycosylation and Glycoproteins Research (7 papers)CAR-T cell therapy research (7 papers)
- Cited by
- HepatologyImmunologyBiotechnology
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Mingqian Feng
45 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 79
- Molecular Biology 598
- Immunology 371
- Oncology 360
- Radiology, Nuclear Medicine and Imaging 295
- Hepatology 178
Countries citing papers authored by Mingqian Feng
This map shows the geographic impact of Mingqian Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingqian Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingqian Feng more than expected).
Fields of papers citing papers by Mingqian Feng
This network shows the impact of papers produced by Mingqian Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingqian Feng. The network helps show where Mingqian Feng may publish in the future.
Co-authorship network of co-authors of Mingqian Feng
This figure shows the co-authorship network connecting the top 25 collaborators of Mingqian Feng. A scholar is included among the top collaborators of Mingqian Feng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingqian Feng. Mingqian Feng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 1 | |
| 6 | 18 | |
| 7 | 4 | |
| 8 | 1 | |
| 9 | 6 | |
| 10 | 1 | |
| 11 | 5 | |
| 12 | 6 | |
| 13 | 10 | |
| 14 | 55 | |
| 15 | 20 | |
| 16 | 38 | |
| 17 | 30 | |
| 18 | 17 | |
| 19 | 52 | |
| 20 | 4 |
About Mingqian Feng
Mingqian Feng is a scholar working on Biotechnology, Immunology and Structural Biology, having authored 49 papers that have together received 1.3k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (14 papers), Glycosylation and Glycoproteins Research (7 papers) and CAR-T cell therapy research (7 papers). The work is most often cited by research in Hepatology (178 citations), Immunology (371 citations) and Biotechnology (125 citations). Mingqian Feng has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Mitchell Ho, Wei Gao, Dimiter S. Dimitrov, Yen Phung, Heungnam Kim, Xin Wei Wang, Min Qian, Yan‐Gao Man, Zhewei Tang and Yifan Zhang. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.